Research graph
References from Case Report: Central nervous system infiltration after allogeneic hematopoietic stem cell transplantation in high-risk myelodysplastic neoplasms. Local targets link to admitted publications; unresolved targets remain external evidence.
Advances and challenges in the treatment of myelodysplastic syndromes
10.1186/s40164-025-00678-9 · 2025 · External reference
Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study
10.1186/s40164-025-00652-5 · 2025 · External reference
Chinese guidelines for diagnosis and treatment of myelodysplastic neoplasms (2026)
10.3760/cma.j.cn121090-20251205-00574 · 2026 · External reference
Four cases of chronic myelomonocytic leukemia
10.3960/jslrt1961.24.95 · 1984 · External reference
Meningeal leukemia in the chronic stage of chronic myelomonocytic leukemia
1988 · External reference
A 45-year-old man with peripheral monocytosis and right hemiparesis
1998 · External reference
Meningeal involvement of chronic myelomonocytic leukemia
10.1007/s00415-003-1138-5 · 2003 · External reference
Unresolved reference
External reference
Lesions of the central nervous system in leukemia: Pathological and magnetic resonance imaging features at presentation in 14 patients
10.3892/ol.2017.7192 · 2017 · External reference
Chronic myelomonocytic leukemia with central nervous system involvement
10.1080/10428194.2017.1422866 · 2018 · External reference
Chronic subdural collection overlying an intra-axial hemorrhagic lesion in chronic myelomonocytic leukemia: special report and review of the literature
10.1080/14737175.2018.1464391 · 2018 · External reference
Isolated CNS relapse in FLT 3 mutation positive CMML post allogeneic stem cell transplant: Report of a rare case
10.4103/ijpm.ijpm_344_20 · 2021 · External reference
Cerebral localization of chronic myelomonocytic leukemia: a case report
10.1186/s13256-021-02947-7 · 2021 · External reference
Cerebral localization of chronic myelomonocytic leukemia and improvement with high‐dose cytarabine: A case report
10.1002/jha2.740 · 2023 · External reference
Young adult myelodysplastic syndrome with central nervous system involvement diagnosed following cerebral embolism
10.11406/rinketsu.59.2583 · 2018 · External reference
The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms
10.1038/s41375-022-01613-1 · 2022 · External reference
Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases
10.2214/ajr.165.3.7645483 · 1995 · External reference
Posterior reversible encephalopathy syndrome (PRES): A narrative review of pathophysiology, clinical insights, and advances in management
10.1186/s12245-026-01138-9 · 2026 · External reference
Unresolved reference
External reference
Chinese consensus on the diagnosis and management of Epstein-Barr virus-related post-transplant lymphoproliferative disorders after hematopoietic stem cell transplantation (2022)
10.3760/cma.j.issn.0253-2727.2022.09.002 · 2022 · External reference
A case of central nervous system post-transplant lymphoproliferative disorder following haploidentical stem cell transplantation in a patient with acute lymphoblastic leukemia
10.1177/09636897221117532 · 2022 · External reference
The international classification of headache disorders, 3rd edition (ICHD-3)
10.1177/0333102417738202 · 2018 · External reference
Human CD38: a (r)evolutionary story of enzymes and receptors
10.1016/s0145-2126(00)00093-x · 2001 · External reference
Chimerism analysis on mononuclear cells in the CSF after allogeneic bone marrow transplantation
10.1038/sj.bmt.1700918 · 1997 · External reference
Central nervous system involvement in adults with acute leukemia: Diagnosis, prevention, and management
10.1007/s11912-022-01220-4 · 2022 · External reference
Metabolic and epigenetic dysregulation in IDH1/2-mutant gliomas: A microglial-mediated mechanism of blood-brain barrier disruption
10.1016/j.intimp.2025.115970 · 2026 · External reference
Impact of TP53 alteration on allogeneic hematopoietic cell transplantation outcomes for myelodysplastic syndromes
10.1038/s41409-025-02511-7 · 2025 · External reference
Impact of TP53 variants and germline mutations on allogeneic stem cell transplantation outcomes in acute myeloid leukemia and myelodysplastic neoplasms
10.1038/s41375-025-02672-w · 2025 · External reference
Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes
10.1182/blood.2024025464 · 2025 · External reference
Unresolved reference
External reference
The utility of stereotactic biopsy of intracranial lesions in the diagnosis of leukemia complicated by central nervous system lesions
10.1186/s41016-025-00392-9 · 2025 · External reference
Platelet transfusion for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
10.1200/jco.2017.76.1734 · 2018 · External reference
Central nervous system involvement at first relapse in patients with acute myeloid leukemia
10.3324/haematol.2011.042960 · 2011 · External reference
Impact of prophylactic intrathecal chemotherapy on CNS relapse rates in AML patients presenting with hyperleukocytosis
10.1080/10428194.2019.1691199 · 2020 · External reference
Diagnosis and management of adult central nervous system leukemia
10.1097/bs9.0000000000000162 · 2023 · External reference
Central nervous system complications after allogeneic hematopoietic stem cell transplantation
10.2217/fon-2017-0274 · 2017 · External reference
Higher positive identification of Malignant CSF cells using the cytocentrifuge than the Suta chamber
10.1590/0004-282x20160120 · 2016 · External reference
